Provided by Tiger Trade Technology Pte. Ltd.

FUDANZHANGJIANG

2.420
+0.0301.26%
Volume:931.00K
Turnover:2.26M
Market Cap:2.51B
PE:-13.72
High:2.440
Open:2.390
Low:2.390
Close:2.390
52wk High:4.370
52wk Low:2.200
Shares:1.04B
HK Float Shares:326.00M
Volume Ratio:1.03
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.176
ROE:-6.89%
ROA:-4.01%
PB:1.02
PE(LYR):-13.72
PS:3.30

Loading ...

FUDANZHANGJIANG Enrols First Patient in Phase I Trial of FZ-P001 Photosensitizer for Ovarian Cancer Surgery Guidance

Bulletin Express
·
Apr 09

FUDANZHANGJIANG (01349) Completes First Patient Enrollment in Phase I Trial for Ovarian Cancer Imaging Agent

Stock News
·
Apr 09

AH Share Premium Data Report for April 9

Stock News
·
Apr 09

Fudan Zhangjiang Invests 210 Million Yuan in Structured Deposit from Pudong Development Bank

Stock News
·
Apr 07

FUDANZHANGJIANG places RMB210 million of idle funds into low-risk SPD Bank structured deposit

Bulletin Express
·
Apr 07

AH Share Premium Rankings as of April 6

Stock News
·
Apr 06

AH Share Premium Rankings for April 3

Stock News
·
Apr 03

FUDANZHANGJIANG Places RMB150.00 Million in 89-Day Principal-Protected Structured Deposit with Bank of China

Bulletin Express
·
Apr 02

Fudan Zhangjiang Invests 150 Million Yuan in Bank of China Structured Deposit

Stock News
·
Apr 02

AH Share Premium Rankings as of April 1

Stock News
·
Apr 01

Strategic Investment in R&D Drives Pipeline Progress: Fudan Zhangjiang Maintains Focus on Long-Term Value in 2025

Deep News
·
Mar 31

FUDANZHANGJIANG (01349) Reports 2025 Annual Results with Shareholder Loss of 157 Million Yuan

Stock News
·
Mar 31

FUDANZHANGJIANG Sets Stage for Ninth Board: Eight-Member Line-up Proposed, Key Executives Retained

Bulletin Express
·
Mar 30

Fudan Zhangjiang Proposes Re-election of Zhao Dajun as Executive Director

Stock News
·
Mar 30

Fudan-Zhangjiang Experiences Sharp Profit Decline: Core Product Fails National Procurement, R&D Costs Strain Operations

Deep News
·
Mar 06

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (01349) Releases Monthly Return on Securities Movements for February 2026

Bulletin Express
·
Mar 02

Fudan Zhangjiang Shares Drop Over 4% Following Report of 2025 Loss

Stock News
·
Mar 02

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (Stock Code: ) Releases Preliminary 2025 Annual Results

Bulletin Express
·
Feb 27

Fudan-Zhangjiang Bio-Pharma (01349) Reports Unchanged Share Capital for January 2026

Bulletin Express
·
Feb 24

Global Market Insights: Penny Stocks To Watch In February 2026

Simply Wall St.
·
Feb 11